Therefore, under pro-inflammatory conditions, such as those induced with the overexpression of TRPC1 or miR-146b, the proliferative capacities and chemosensitivities of certain cancers increase, whereas migratory capacities diminish. The gene discussed is TRPC1; the disease is cancer.